Background: Since the outbreak of coronavirus disease 2019 (COVID-19) was announced in Wuhan City (China) on 31st December 2019, pharmacists worldwide have been playing a vital role in minimizing the adverse effects of the pandemic on healthcare systems. Objective: The guideline aims to provide clear, relevant, and comprehensive instructions for pharmacy staff on how to manage different medication processes during the COVID-19 pandemic. Method: This editorial discusses the development of a guideline named “CORONA VIRUS (COVID-19) Infection Prevention and Control Guidelines for Pharmacy Personnel in the Hospital Setting” by Pharmaceutical Care Services in King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. Result: Pharmaceutical Care Services established the guideline in March 2020, which was then updated in June 2020 by Pharmaceutical Care Services in King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia to respond rapidly to the urgent need for a comprehensive approach to manage medication processes during the COVID-19 pandemic and monitor the implementation overall the hospital. Conclusion: This guideline is a reliable and comprehensive source of information and can be implemented by any pharmacy department within the Kingdom of Saudi Arabia and internationally. To the best of our knowledge, this work might be the first in the field of management of medication processes.
| Published in | American Journal of BioScience (Volume 9, Issue 4) |
| DOI | 10.11648/j.ajbio.20210904.14 |
| Page(s) | 134-140 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
King Abdulaziz Medical City, Hospital Pharmacy Services, Frontline Pharmacists, Infection Prevention and Control Guidelines, COVID-19, Pandemic
| [1] | World Health Organization. Report of the WHO-China Joint Mission on Coronavirus Disease 2019 (COVID-19). February, 2020. https://www.who.int/docs/default-source/coronaviruse/who-china-joint-mission-on-covid-19-final-report.pdf (accessed March 13, 2020). Retrieved from https://www.who.int/docs/default-source/coronaviruse/who-chinajoint-mission-on-covid-19-final-report.pdf (on 16.05.2020). |
| [2] | COVID-19: epidemiology, virology, and clinical features (Guidance) organisation: Public Health England. https://www.gov.uk/government/publications/wuhan-novel-coronavirusbackground-information/wuhan-novel-coronavirus-epidemiology-virology-and-clinicalfeatures#epidemiology) (Accessed 14/05/2020). |
| [3] | World Health Organization. WHO Virtual press conference on COVID-19. March 11, 2020. https://www.who.int/docs/default-source/coronaviruse/transcripts/ who-audioemergencies-coronavirus-press-conference-full-andfinal11mar2020.pdf?sfvrsn=cb432bb3_2 (Accessed March 16, 2020). |
| [4] | Bedford, J. Enria, D. Giesecke, J. Heymann, D. L. Ihekweazu, C. Kobinger, G. (2020). COVID-19: towards controlling of a pandemic. The Lancet. 395 (10229): 1015-1018 DOI 10.1016/S0140-6736(20)30673-5. |
| [5] | World Health Organization. (2020). Rational use of personal protective equipment for coronavirus disease 2019 (COVID-19) and considerations during severe shortages. WHO. April: 1-28 https://apps.who.int/iris/handle/10665/331695 (Accessed July 2020). |
| [6] | ISMP. (2020). SPECIAL Considerations for ADC usage during COVID-19. Medication Safety Alert Acute Care. 25 (7). https://ismp.org/sites/default/files/newsletterissues/20200416.pdf |
| [7] | Elbeddini, A. Prabaharan, T. Almasalkhi, S. Tran, C. (2020). Pharmacists and COVID-19. Journal of Pharmaceutical Policy and Practice. 3: 1-4. |
| [8] | Quality Improvement Section in Pharmaceutical care services. (2020). CORONAVIRUS (COVID-19) Infection Control Guidelines for Pharmacy Personnel in the Hospital Setting 3rd version. Internal Guidelines – Ministry of National Guard Health Affairs – Central Region. Unpublished. |
| [9] | World Health Organization WHO. Hand Hygiene: Why, How & When?. 2009, August. https://www.who.int/gpsc/5may/Hand_Hygiene_Why_How_and_When_Brochure.pdf?ua=1 |
| [10] | Chinese Pharmaceutical Association. (2020). CORONAVIRUS 2019-nCoV INFECTION: Expert Consensus on Guidance and Prevention Strategies for Hospital Pharmacists and the Pharmacy Workforce (1stEdition). February: 06. https://www.fip.org/files/content/priorityareas/coronavirus/CPA-CORONAVIRUS-2019-nCoV-Expert-Consensus-on-Guidance-and-Prevention.pdf |
| [11] | International Pharmaceutical Federation (Health Advisory). (2020) COVID-19 pandemic: Guidelines for pharmacists and the pharmacy workforce. March: 26. https://www.fip.org/files/content/priority-areas/coronavirus/COVID-19-Guidelines-forpharmacists-and-the-pharmacy-workforce.pdf |
| [12] | “What is a Pharmacy Aide?” Learn.org.https://learn.org/articles/What_is_a_Pharmacy_Aide.html (Accessed 12. August. 2020). |
| [13] | Pharmaceutical Care Services. (2016) Departmental Policy and Procedure: 7330_16_02_00_Pneumatic_Tube_System. Internal DPP - Ministry of National Guard Health Affairs – Central Region. Unpublished. |
| [14] | Al-Quteimat OM, Amer AM. SARS-CoV-2 outbreak: how can pharmacists help? Res Soc Adm Pharm. 2020; S1551-7411 (20): 30238–2. |
| [15] | Bukhari N, Rasheed H, Nayyer B, Babar ZUD. Pharmacists at the frontline beating the COVID-19 pandemic. J of Pharm Policy and Pract. 2020; 13: 8. |
APA Style
Haya Almufrij, Khalil Almajed, Fawziah Almutairi, Asma Altoub, Tahani Alsufian, et al. (2021). COVID-19 Infection Prevention and Control Guidelines for Pharmacy Personnel in King Abdulaziz Medical City-Riyadh, Kingdom of Saudi Arabia. American Journal of BioScience, 9(4), 134-140. https://doi.org/10.11648/j.ajbio.20210904.14
ACS Style
Haya Almufrij; Khalil Almajed; Fawziah Almutairi; Asma Altoub; Tahani Alsufian, et al. COVID-19 Infection Prevention and Control Guidelines for Pharmacy Personnel in King Abdulaziz Medical City-Riyadh, Kingdom of Saudi Arabia. Am. J. BioScience 2021, 9(4), 134-140. doi: 10.11648/j.ajbio.20210904.14
AMA Style
Haya Almufrij, Khalil Almajed, Fawziah Almutairi, Asma Altoub, Tahani Alsufian, et al. COVID-19 Infection Prevention and Control Guidelines for Pharmacy Personnel in King Abdulaziz Medical City-Riyadh, Kingdom of Saudi Arabia. Am J BioScience. 2021;9(4):134-140. doi: 10.11648/j.ajbio.20210904.14
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.ajbio.20210904.14,
author = {Haya Almufrij and Khalil Almajed and Fawziah Almutairi and Asma Altoub and Tahani Alsufian and Saad Alobaidi and Hamza Alsamanodi and Mohammed Alotaibi and Hind Albadali and Abdullah Al Romi and Fars Alrowili and Saleh Alanazi},
title = {COVID-19 Infection Prevention and Control Guidelines for Pharmacy Personnel in King Abdulaziz Medical City-Riyadh, Kingdom of Saudi Arabia},
journal = {American Journal of BioScience},
volume = {9},
number = {4},
pages = {134-140},
doi = {10.11648/j.ajbio.20210904.14},
url = {https://doi.org/10.11648/j.ajbio.20210904.14},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbio.20210904.14},
abstract = {Background: Since the outbreak of coronavirus disease 2019 (COVID-19) was announced in Wuhan City (China) on 31st December 2019, pharmacists worldwide have been playing a vital role in minimizing the adverse effects of the pandemic on healthcare systems. Objective: The guideline aims to provide clear, relevant, and comprehensive instructions for pharmacy staff on how to manage different medication processes during the COVID-19 pandemic. Method: This editorial discusses the development of a guideline named “CORONA VIRUS (COVID-19) Infection Prevention and Control Guidelines for Pharmacy Personnel in the Hospital Setting” by Pharmaceutical Care Services in King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. Result: Pharmaceutical Care Services established the guideline in March 2020, which was then updated in June 2020 by Pharmaceutical Care Services in King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia to respond rapidly to the urgent need for a comprehensive approach to manage medication processes during the COVID-19 pandemic and monitor the implementation overall the hospital. Conclusion: This guideline is a reliable and comprehensive source of information and can be implemented by any pharmacy department within the Kingdom of Saudi Arabia and internationally. To the best of our knowledge, this work might be the first in the field of management of medication processes.},
year = {2021}
}
TY - JOUR T1 - COVID-19 Infection Prevention and Control Guidelines for Pharmacy Personnel in King Abdulaziz Medical City-Riyadh, Kingdom of Saudi Arabia AU - Haya Almufrij AU - Khalil Almajed AU - Fawziah Almutairi AU - Asma Altoub AU - Tahani Alsufian AU - Saad Alobaidi AU - Hamza Alsamanodi AU - Mohammed Alotaibi AU - Hind Albadali AU - Abdullah Al Romi AU - Fars Alrowili AU - Saleh Alanazi Y1 - 2021/07/21 PY - 2021 N1 - https://doi.org/10.11648/j.ajbio.20210904.14 DO - 10.11648/j.ajbio.20210904.14 T2 - American Journal of BioScience JF - American Journal of BioScience JO - American Journal of BioScience SP - 134 EP - 140 PB - Science Publishing Group SN - 2330-0167 UR - https://doi.org/10.11648/j.ajbio.20210904.14 AB - Background: Since the outbreak of coronavirus disease 2019 (COVID-19) was announced in Wuhan City (China) on 31st December 2019, pharmacists worldwide have been playing a vital role in minimizing the adverse effects of the pandemic on healthcare systems. Objective: The guideline aims to provide clear, relevant, and comprehensive instructions for pharmacy staff on how to manage different medication processes during the COVID-19 pandemic. Method: This editorial discusses the development of a guideline named “CORONA VIRUS (COVID-19) Infection Prevention and Control Guidelines for Pharmacy Personnel in the Hospital Setting” by Pharmaceutical Care Services in King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia. Result: Pharmaceutical Care Services established the guideline in March 2020, which was then updated in June 2020 by Pharmaceutical Care Services in King Abdulaziz Medical City, Riyadh, Kingdom of Saudi Arabia to respond rapidly to the urgent need for a comprehensive approach to manage medication processes during the COVID-19 pandemic and monitor the implementation overall the hospital. Conclusion: This guideline is a reliable and comprehensive source of information and can be implemented by any pharmacy department within the Kingdom of Saudi Arabia and internationally. To the best of our knowledge, this work might be the first in the field of management of medication processes. VL - 9 IS - 4 ER -
Email: